Nonaddictive hydromorphone hydrogel for muscle and joint pain
Official title: Nonaddictive opioid prodrug nanomedicine for musculoskeletal pain
Funded at University of Nebraska Medical Center · NIH-11136478 · Data updated 2026-11-12
A long-lasting, non-addictive gel medicine that releases pain relief right at sore muscles and joints without reaching the brain.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project start | September 7, 2022 |
| Project end | July 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $430,589 |
| NIH project number | 5R01AR080500-04 |
| Project ID | NIH-11136478 on NIH RePORTER |
Who could benefit from this research
✓Could help
People with localized musculoskeletal pain such as osteoarthritis or joint/muscle pain who need stronger, targeted relief and want to avoid systemic opioids would be the ideal candidates.
✕Less likely to help
Patients with widespread or centrally mediated pain conditions, those needing whole-body opioid effects, or anyone with allergies to the components likely would not benefit from this local gel approach.
What this research studies
You would receive a temperature-sensitive gel placed near a painful joint or muscle that slowly releases a modified form of the opioid hydromorphone where it is needed. The medicine is attached to a large carrier so it stays at the site and is taken up by local cells, releasing pain relief over many days while limiting drug exposure to the spinal cord and brain. In animal models of osteoarthritis the gel provided strong pain relief for more than two weeks without signs of central opioid effects. The team aims to make pain control that is potent yet avoids the addiction and systemic side effects of traditional opioids.
Why it matters
Potential benefit: If successful, this approach could give longer-lasting local pain relief for musculoskeletal conditions while reducing the risk of addiction and systemic side effects.
How similar studies have gone: Related local opioid-delivery ideas have shown promising results in animal models, but similar approaches remain largely preclinical and human data are limited.
Where this research is happening
-
University of Nebraska Medical Center
Omaha, United States Active
Researchers
- Principal investigator: Wang, Dong — University of Nebraska Medical Center
- Study coordinator: Wang, Dong
Related research
Other NIH-funded projects on the same topics.
-
mHealth tool to boost physical therapy outcomes for adults with musculoskeletal pain
A mobile health app is being tested to help adults in physical therapy stay on track with home exercises and improve pain and function.
-
Biopsychosocial factors in pediatric chronic musculoskeletal pain
A study at Cincinnati Children’s Hospital will look at how biological, psychological, and social factors contribute to chronic muscle and joint pain in young people to find better ways to help them.
-
Nonaddictive pain-relief prodrug gel for joint and musculoskeletal pain
A new, nonaddictive pain-relief gel uses a hydromorphone prodrug that stays at the site of pain to reduce pain without strong addiction risk.
-
Neurobiological and psychosocial factors that may turn acute teen pain into chronic pain
A study following teenagers with acute musculoskeletal pain to understand why some develop chronic pain and how biology and psychology interact to shape their outcomes.
-
Tech-guided walking plus Tai Chi to improve function for veterans with COPD and chronic pain
This program helps veterans with COPD and long-term muscle or joint pain use a web-based step program together with Tai Chi to move more and feel stronger.
-
Resilience Coaching for Teens with Long-Lasting Muscle and Bone Pain
This project offers resilience coaching to help teenagers manage ongoing muscle and bone pain and improve their well-being.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.